Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.

Pneumocystis carinii pneumonia is often the terminal event for patients with the acquired immunodeficiency syndrome. Eflornithine (DL-alpha-difluoromethylornithine [DFMO]; Ornidyl; Merrell Dow Research Institute, Cincinnati, Ohio) has been used successfully against this protozoan disease in limited...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Clarkson, A B, Williams, D E, Rosenberg, C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172369/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3142346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.8.1158
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!